nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbidopa—L-DOPA—Melphalan—ovarian cancer	0.718	1	CrCrCtD
Carbidopa—DDC—Dopaminergic Neurogenesis—LMX1A—ovarian cancer	0.0102	0.337	CbGpPWpGaD
Carbidopa—DDC—Amine-derived hormones—SLC5A5—ovarian cancer	0.00353	0.117	CbGpPWpGaD
Carbidopa—DDC—Dopamine metabolism—SOD1—ovarian cancer	0.00344	0.114	CbGpPWpGaD
Carbidopa—Isoprenaline—MAPK1—ovarian cancer	0.00288	1	CrCbGaD
Carbidopa—DDC—Parkinsons Disease Pathway—PARK2—ovarian cancer	0.00234	0.0775	CbGpPWpGaD
Carbidopa—DDC—Tryptophan metabolism—CYP1B1—ovarian cancer	0.0014	0.0465	CbGpPWpGaD
Carbidopa—DDC—Parkinsons Disease Pathway—CCNE1—ovarian cancer	0.00135	0.0446	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—TOP1—ovarian cancer	0.000991	0.0328	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—PPP1CC—ovarian cancer	0.000866	0.0287	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—HNF1B—ovarian cancer	0.000751	0.0249	CbGpPWpGaD
Carbidopa—DDC—Dopaminergic Neurogenesis—STAT3—ovarian cancer	0.000694	0.023	CbGpPWpGaD
Carbidopa—DDC—Parkinsons Disease Pathway—CASP3—ovarian cancer	0.000684	0.0227	CbGpPWpGaD
Carbidopa—DDC—Amino acid and derivative metabolism—SLC5A5—ovarian cancer	0.000491	0.0163	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—TYMS—ovarian cancer	0.000349	0.0116	CbGpPWpGaD
Carbidopa—DDC—Metabolism—NME2—ovarian cancer	0.000298	0.00987	CbGpPWpGaD
Carbidopa—Dermatitis—Melphalan—ovarian cancer	0.000295	0.00118	CcSEcCtD
Carbidopa—Cough—Paclitaxel—ovarian cancer	0.000295	0.00118	CcSEcCtD
Carbidopa—Asthenia—Vinorelbine—ovarian cancer	0.000294	0.00118	CcSEcCtD
Carbidopa—Orthostatic hypotension—Epirubicin—ovarian cancer	0.000293	0.00117	CcSEcCtD
Carbidopa—Convulsion—Paclitaxel—ovarian cancer	0.000292	0.00117	CcSEcCtD
Carbidopa—Hypertension—Paclitaxel—ovarian cancer	0.000291	0.00117	CcSEcCtD
Carbidopa—Alopecia—Docetaxel—ovarian cancer	0.00029	0.00116	CcSEcCtD
Carbidopa—Pruritus—Vinorelbine—ovarian cancer	0.00029	0.00116	CcSEcCtD
Carbidopa—Mental disorder—Docetaxel—ovarian cancer	0.000288	0.00115	CcSEcCtD
Carbidopa—Chest pain—Paclitaxel—ovarian cancer	0.000287	0.00115	CcSEcCtD
Carbidopa—Nasopharyngitis—Epirubicin—ovarian cancer	0.000287	0.00115	CcSEcCtD
Carbidopa—Anxiety—Paclitaxel—ovarian cancer	0.000286	0.00115	CcSEcCtD
Carbidopa—Nausea—Topotecan—ovarian cancer	0.000284	0.00114	CcSEcCtD
Carbidopa—Discomfort—Paclitaxel—ovarian cancer	0.000284	0.00114	CcSEcCtD
Carbidopa—Gastritis—Epirubicin—ovarian cancer	0.000284	0.00114	CcSEcCtD
Carbidopa—Dry mouth—Paclitaxel—ovarian cancer	0.000281	0.00113	CcSEcCtD
Carbidopa—Diarrhoea—Vinorelbine—ovarian cancer	0.00028	0.00112	CcSEcCtD
Carbidopa—Dysgeusia—Docetaxel—ovarian cancer	0.00028	0.00112	CcSEcCtD
Carbidopa—Ataxia—Doxorubicin—ovarian cancer	0.000279	0.00112	CcSEcCtD
Carbidopa—Nausea—Melphalan—ovarian cancer	0.000278	0.00112	CcSEcCtD
Carbidopa—Confusional state—Paclitaxel—ovarian cancer	0.000278	0.00111	CcSEcCtD
Carbidopa—Blood creatinine increased—Doxorubicin—ovarian cancer	0.000278	0.00111	CcSEcCtD
Carbidopa—Dysphagia—Epirubicin—ovarian cancer	0.000277	0.00111	CcSEcCtD
Carbidopa—Back pain—Docetaxel—ovarian cancer	0.000277	0.00111	CcSEcCtD
Carbidopa—Oedema—Paclitaxel—ovarian cancer	0.000275	0.0011	CcSEcCtD
Carbidopa—Muscle spasms—Docetaxel—ovarian cancer	0.000275	0.0011	CcSEcCtD
Carbidopa—Infection—Paclitaxel—ovarian cancer	0.000274	0.0011	CcSEcCtD
Carbidopa—Shock—Paclitaxel—ovarian cancer	0.000271	0.00109	CcSEcCtD
Carbidopa—Dizziness—Vinorelbine—ovarian cancer	0.000271	0.00109	CcSEcCtD
Carbidopa—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.000271	0.00109	CcSEcCtD
Carbidopa—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00027	0.00108	CcSEcCtD
Carbidopa—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000266	0.00107	CcSEcCtD
Carbidopa—Nasopharyngitis—Doxorubicin—ovarian cancer	0.000265	0.00106	CcSEcCtD
Carbidopa—Anaemia—Docetaxel—ovarian cancer	0.000264	0.00106	CcSEcCtD
Carbidopa—Anorexia—Paclitaxel—ovarian cancer	0.000263	0.00105	CcSEcCtD
Carbidopa—Gastritis—Doxorubicin—ovarian cancer	0.000262	0.00105	CcSEcCtD
Carbidopa—Vomiting—Vinorelbine—ovarian cancer	0.00026	0.00104	CcSEcCtD
Carbidopa—Rash—Vinorelbine—ovarian cancer	0.000258	0.00104	CcSEcCtD
Carbidopa—Dermatitis—Vinorelbine—ovarian cancer	0.000258	0.00103	CcSEcCtD
Carbidopa—Hypotension—Paclitaxel—ovarian cancer	0.000257	0.00103	CcSEcCtD
Carbidopa—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000257	0.00103	CcSEcCtD
Carbidopa—Headache—Vinorelbine—ovarian cancer	0.000257	0.00103	CcSEcCtD
Carbidopa—Syncope—Docetaxel—ovarian cancer	0.000257	0.00103	CcSEcCtD
Carbidopa—Dysphagia—Doxorubicin—ovarian cancer	0.000256	0.00103	CcSEcCtD
Carbidopa—Leukopenia—Docetaxel—ovarian cancer	0.000256	0.00103	CcSEcCtD
Carbidopa—Pollakiuria—Epirubicin—ovarian cancer	0.000256	0.00103	CcSEcCtD
Carbidopa—Palpitations—Docetaxel—ovarian cancer	0.000253	0.00101	CcSEcCtD
Carbidopa—Weight increased—Epirubicin—ovarian cancer	0.000252	0.00101	CcSEcCtD
Carbidopa—Loss of consciousness—Docetaxel—ovarian cancer	0.000251	0.00101	CcSEcCtD
Carbidopa—Weight decreased—Epirubicin—ovarian cancer	0.000251	0.00101	CcSEcCtD
Carbidopa—Cough—Docetaxel—ovarian cancer	0.00025	0.001	CcSEcCtD
Carbidopa—Insomnia—Paclitaxel—ovarian cancer	0.000249	0.000999	CcSEcCtD
Carbidopa—Convulsion—Docetaxel—ovarian cancer	0.000248	0.000994	CcSEcCtD
Carbidopa—Paraesthesia—Paclitaxel—ovarian cancer	0.000247	0.000992	CcSEcCtD
Carbidopa—Hypertension—Docetaxel—ovarian cancer	0.000247	0.000991	CcSEcCtD
Carbidopa—Dyspnoea—Paclitaxel—ovarian cancer	0.000246	0.000985	CcSEcCtD
Carbidopa—Somnolence—Paclitaxel—ovarian cancer	0.000245	0.000982	CcSEcCtD
Carbidopa—Chest pain—Docetaxel—ovarian cancer	0.000244	0.000977	CcSEcCtD
Carbidopa—Nausea—Vinorelbine—ovarian cancer	0.000243	0.000976	CcSEcCtD
Carbidopa—Dyspepsia—Paclitaxel—ovarian cancer	0.000242	0.000973	CcSEcCtD
Carbidopa—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000242	0.000971	CcSEcCtD
Carbidopa—Urinary tract infection—Epirubicin—ovarian cancer	0.00024	0.000963	CcSEcCtD
Carbidopa—Decreased appetite—Paclitaxel—ovarian cancer	0.000239	0.000961	CcSEcCtD
Carbidopa—Dry mouth—Docetaxel—ovarian cancer	0.000238	0.000956	CcSEcCtD
Carbidopa—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000238	0.000955	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000238	0.000954	CcSEcCtD
Carbidopa—Fatigue—Paclitaxel—ovarian cancer	0.000237	0.000953	CcSEcCtD
Carbidopa—Pollakiuria—Doxorubicin—ovarian cancer	0.000237	0.00095	CcSEcCtD
Carbidopa—Constipation—Paclitaxel—ovarian cancer	0.000236	0.000945	CcSEcCtD
Carbidopa—Pain—Paclitaxel—ovarian cancer	0.000236	0.000945	CcSEcCtD
Carbidopa—Confusional state—Docetaxel—ovarian cancer	0.000235	0.000944	CcSEcCtD
Carbidopa—Oedema—Docetaxel—ovarian cancer	0.000233	0.000937	CcSEcCtD
Carbidopa—Weight increased—Doxorubicin—ovarian cancer	0.000233	0.000935	CcSEcCtD
Carbidopa—Infection—Docetaxel—ovarian cancer	0.000232	0.00093	CcSEcCtD
Carbidopa—Weight decreased—Doxorubicin—ovarian cancer	0.000232	0.00093	CcSEcCtD
Carbidopa—DDC—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	0.000231	0.00765	CbGpPWpGaD
Carbidopa—Agranulocytosis—Epirubicin—ovarian cancer	0.00023	0.000924	CcSEcCtD
Carbidopa—Shock—Docetaxel—ovarian cancer	0.00023	0.000921	CcSEcCtD
Carbidopa—Thrombocytopenia—Docetaxel—ovarian cancer	0.000229	0.000917	CcSEcCtD
Carbidopa—Feeling abnormal—Paclitaxel—ovarian cancer	0.000227	0.000911	CcSEcCtD
Carbidopa—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000225	0.000904	CcSEcCtD
Carbidopa—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000224	0.000898	CcSEcCtD
Carbidopa—Haemoglobin—Epirubicin—ovarian cancer	0.000223	0.000894	CcSEcCtD
Carbidopa—Anorexia—Docetaxel—ovarian cancer	0.000223	0.000893	CcSEcCtD
Carbidopa—Rhinitis—Epirubicin—ovarian cancer	0.000222	0.000891	CcSEcCtD
Carbidopa—Urinary tract infection—Doxorubicin—ovarian cancer	0.000222	0.000891	CcSEcCtD
Carbidopa—Haemorrhage—Epirubicin—ovarian cancer	0.000222	0.000889	CcSEcCtD
Carbidopa—DDC—SIDS Susceptibility Pathways—CASP3—ovarian cancer	0.000221	0.00732	CbGpPWpGaD
Carbidopa—Hypoaesthesia—Epirubicin—ovarian cancer	0.000221	0.000885	CcSEcCtD
Carbidopa—Urinary tract disorder—Epirubicin—ovarian cancer	0.000219	0.000878	CcSEcCtD
Carbidopa—Urticaria—Paclitaxel—ovarian cancer	0.000219	0.000878	CcSEcCtD
Carbidopa—Hypotension—Docetaxel—ovarian cancer	0.000218	0.000875	CcSEcCtD
Carbidopa—Body temperature increased—Paclitaxel—ovarian cancer	0.000218	0.000874	CcSEcCtD
Carbidopa—Abdominal pain—Paclitaxel—ovarian cancer	0.000218	0.000874	CcSEcCtD
Carbidopa—Urethral disorder—Epirubicin—ovarian cancer	0.000217	0.000872	CcSEcCtD
Carbidopa—Agranulocytosis—Doxorubicin—ovarian cancer	0.000213	0.000855	CcSEcCtD
Carbidopa—DDC—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	0.000213	0.00706	CbGpPWpGaD
Carbidopa—Insomnia—Docetaxel—ovarian cancer	0.000211	0.000847	CcSEcCtD
Carbidopa—Paraesthesia—Docetaxel—ovarian cancer	0.00021	0.000841	CcSEcCtD
Carbidopa—Dyspnoea—Docetaxel—ovarian cancer	0.000208	0.000835	CcSEcCtD
Carbidopa—Somnolence—Docetaxel—ovarian cancer	0.000208	0.000833	CcSEcCtD
Carbidopa—Haemoglobin—Doxorubicin—ovarian cancer	0.000206	0.000827	CcSEcCtD
Carbidopa—Flushing—Epirubicin—ovarian cancer	0.000206	0.000825	CcSEcCtD
Carbidopa—Rhinitis—Doxorubicin—ovarian cancer	0.000206	0.000825	CcSEcCtD
Carbidopa—Dyspepsia—Docetaxel—ovarian cancer	0.000206	0.000824	CcSEcCtD
Carbidopa—Haemorrhage—Doxorubicin—ovarian cancer	0.000205	0.000823	CcSEcCtD
Carbidopa—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000204	0.000819	CcSEcCtD
Carbidopa—Decreased appetite—Docetaxel—ovarian cancer	0.000203	0.000814	CcSEcCtD
Carbidopa—Hypersensitivity—Paclitaxel—ovarian cancer	0.000203	0.000814	CcSEcCtD
Carbidopa—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000203	0.000813	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000202	0.000809	CcSEcCtD
Carbidopa—Fatigue—Docetaxel—ovarian cancer	0.000201	0.000807	CcSEcCtD
Carbidopa—Urethral disorder—Doxorubicin—ovarian cancer	0.000201	0.000807	CcSEcCtD
Carbidopa—Pain—Docetaxel—ovarian cancer	0.0002	0.000801	CcSEcCtD
Carbidopa—Constipation—Docetaxel—ovarian cancer	0.0002	0.000801	CcSEcCtD
Carbidopa—Asthenia—Paclitaxel—ovarian cancer	0.000198	0.000793	CcSEcCtD
Carbidopa—Alopecia—Epirubicin—ovarian cancer	0.000196	0.000786	CcSEcCtD
Carbidopa—Pruritus—Paclitaxel—ovarian cancer	0.000195	0.000782	CcSEcCtD
Carbidopa—Mental disorder—Epirubicin—ovarian cancer	0.000194	0.000779	CcSEcCtD
Carbidopa—Feeling abnormal—Docetaxel—ovarian cancer	0.000192	0.000772	CcSEcCtD
Carbidopa—DDC—Metabolism—CYTB—ovarian cancer	0.000192	0.00636	CbGpPWpGaD
Carbidopa—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000191	0.000766	CcSEcCtD
Carbidopa—Flushing—Doxorubicin—ovarian cancer	0.00019	0.000764	CcSEcCtD
Carbidopa—Flatulence—Epirubicin—ovarian cancer	0.00019	0.000763	CcSEcCtD
Carbidopa—Tension—Epirubicin—ovarian cancer	0.000189	0.00076	CcSEcCtD
Carbidopa—Dysgeusia—Epirubicin—ovarian cancer	0.000189	0.000758	CcSEcCtD
Carbidopa—Diarrhoea—Paclitaxel—ovarian cancer	0.000188	0.000756	CcSEcCtD
Carbidopa—DDC—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	0.000187	0.00621	CbGpPWpGaD
Carbidopa—Nervousness—Epirubicin—ovarian cancer	0.000187	0.000752	CcSEcCtD
Carbidopa—Back pain—Epirubicin—ovarian cancer	0.000187	0.000749	CcSEcCtD
Carbidopa—Muscle spasms—Epirubicin—ovarian cancer	0.000186	0.000744	CcSEcCtD
Carbidopa—Abdominal pain—Docetaxel—ovarian cancer	0.000185	0.00074	CcSEcCtD
Carbidopa—Body temperature increased—Docetaxel—ovarian cancer	0.000185	0.00074	CcSEcCtD
Carbidopa—Dizziness—Paclitaxel—ovarian cancer	0.000182	0.000731	CcSEcCtD
Carbidopa—Vision blurred—Epirubicin—ovarian cancer	0.000182	0.000729	CcSEcCtD
Carbidopa—Alopecia—Doxorubicin—ovarian cancer	0.000181	0.000727	CcSEcCtD
Carbidopa—Mental disorder—Doxorubicin—ovarian cancer	0.00018	0.000721	CcSEcCtD
Carbidopa—Ill-defined disorder—Epirubicin—ovarian cancer	0.000179	0.000718	CcSEcCtD
Carbidopa—Anaemia—Epirubicin—ovarian cancer	0.000178	0.000715	CcSEcCtD
Carbidopa—Agitation—Epirubicin—ovarian cancer	0.000177	0.000711	CcSEcCtD
Carbidopa—Flatulence—Doxorubicin—ovarian cancer	0.000176	0.000706	CcSEcCtD
Carbidopa—Tension—Doxorubicin—ovarian cancer	0.000175	0.000703	CcSEcCtD
Carbidopa—Vomiting—Paclitaxel—ovarian cancer	0.000175	0.000703	CcSEcCtD
Carbidopa—Dysgeusia—Doxorubicin—ovarian cancer	0.000175	0.000701	CcSEcCtD
Carbidopa—Malaise—Epirubicin—ovarian cancer	0.000174	0.000698	CcSEcCtD
Carbidopa—Rash—Paclitaxel—ovarian cancer	0.000174	0.000697	CcSEcCtD
Carbidopa—Dermatitis—Paclitaxel—ovarian cancer	0.000174	0.000696	CcSEcCtD
Carbidopa—Nervousness—Doxorubicin—ovarian cancer	0.000173	0.000696	CcSEcCtD
Carbidopa—Syncope—Epirubicin—ovarian cancer	0.000173	0.000694	CcSEcCtD
Carbidopa—Leukopenia—Epirubicin—ovarian cancer	0.000173	0.000693	CcSEcCtD
Carbidopa—Back pain—Doxorubicin—ovarian cancer	0.000173	0.000693	CcSEcCtD
Carbidopa—Headache—Paclitaxel—ovarian cancer	0.000173	0.000692	CcSEcCtD
Carbidopa—Hypersensitivity—Docetaxel—ovarian cancer	0.000172	0.00069	CcSEcCtD
Carbidopa—Muscle spasms—Doxorubicin—ovarian cancer	0.000172	0.000689	CcSEcCtD
Carbidopa—Palpitations—Epirubicin—ovarian cancer	0.000171	0.000684	CcSEcCtD
Carbidopa—Loss of consciousness—Epirubicin—ovarian cancer	0.00017	0.00068	CcSEcCtD
Carbidopa—DDC—Circadian rythm related genes—PTEN—ovarian cancer	0.000169	0.00562	CbGpPWpGaD
Carbidopa—Cough—Epirubicin—ovarian cancer	0.000168	0.000675	CcSEcCtD
Carbidopa—Vision blurred—Doxorubicin—ovarian cancer	0.000168	0.000675	CcSEcCtD
Carbidopa—DDC—Metabolism—BRIP1—ovarian cancer	0.000168	0.00556	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PPP1CC—ovarian cancer	0.000168	0.00556	CbGpPWpGaD
Carbidopa—Asthenia—Docetaxel—ovarian cancer	0.000168	0.000672	CcSEcCtD
Carbidopa—Convulsion—Epirubicin—ovarian cancer	0.000167	0.000671	CcSEcCtD
Carbidopa—Hypertension—Epirubicin—ovarian cancer	0.000167	0.000668	CcSEcCtD
Carbidopa—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000166	0.000665	CcSEcCtD
Carbidopa—Pruritus—Docetaxel—ovarian cancer	0.000165	0.000663	CcSEcCtD
Carbidopa—Anaemia—Doxorubicin—ovarian cancer	0.000165	0.000662	CcSEcCtD
Carbidopa—Chest pain—Epirubicin—ovarian cancer	0.000164	0.000659	CcSEcCtD
Carbidopa—Agitation—Doxorubicin—ovarian cancer	0.000164	0.000658	CcSEcCtD
Carbidopa—Anxiety—Epirubicin—ovarian cancer	0.000164	0.000657	CcSEcCtD
Carbidopa—Nausea—Paclitaxel—ovarian cancer	0.000164	0.000656	CcSEcCtD
Carbidopa—Discomfort—Epirubicin—ovarian cancer	0.000162	0.000651	CcSEcCtD
Carbidopa—Malaise—Doxorubicin—ovarian cancer	0.000161	0.000646	CcSEcCtD
Carbidopa—Dry mouth—Epirubicin—ovarian cancer	0.000161	0.000644	CcSEcCtD
Carbidopa—Syncope—Doxorubicin—ovarian cancer	0.00016	0.000642	CcSEcCtD
Carbidopa—Leukopenia—Doxorubicin—ovarian cancer	0.00016	0.000641	CcSEcCtD
Carbidopa—Diarrhoea—Docetaxel—ovarian cancer	0.00016	0.000641	CcSEcCtD
Carbidopa—Confusional state—Epirubicin—ovarian cancer	0.000159	0.000637	CcSEcCtD
Carbidopa—Palpitations—Doxorubicin—ovarian cancer	0.000158	0.000633	CcSEcCtD
Carbidopa—Oedema—Epirubicin—ovarian cancer	0.000157	0.000632	CcSEcCtD
Carbidopa—Loss of consciousness—Doxorubicin—ovarian cancer	0.000157	0.000629	CcSEcCtD
Carbidopa—Infection—Epirubicin—ovarian cancer	0.000156	0.000628	CcSEcCtD
Carbidopa—Cough—Doxorubicin—ovarian cancer	0.000156	0.000625	CcSEcCtD
Carbidopa—Shock—Epirubicin—ovarian cancer	0.000155	0.000622	CcSEcCtD
Carbidopa—Convulsion—Doxorubicin—ovarian cancer	0.000155	0.000621	CcSEcCtD
Carbidopa—Dizziness—Docetaxel—ovarian cancer	0.000154	0.000619	CcSEcCtD
Carbidopa—Thrombocytopenia—Epirubicin—ovarian cancer	0.000154	0.000619	CcSEcCtD
Carbidopa—Hypertension—Doxorubicin—ovarian cancer	0.000154	0.000618	CcSEcCtD
Carbidopa—Hyperhidrosis—Epirubicin—ovarian cancer	0.000152	0.000611	CcSEcCtD
Carbidopa—Chest pain—Doxorubicin—ovarian cancer	0.000152	0.00061	CcSEcCtD
Carbidopa—Anxiety—Doxorubicin—ovarian cancer	0.000151	0.000608	CcSEcCtD
Carbidopa—Discomfort—Doxorubicin—ovarian cancer	0.00015	0.000602	CcSEcCtD
Carbidopa—Anorexia—Epirubicin—ovarian cancer	0.00015	0.000602	CcSEcCtD
Carbidopa—Dry mouth—Doxorubicin—ovarian cancer	0.000149	0.000596	CcSEcCtD
Carbidopa—Vomiting—Docetaxel—ovarian cancer	0.000148	0.000596	CcSEcCtD
Carbidopa—Rash—Docetaxel—ovarian cancer	0.000147	0.000591	CcSEcCtD
Carbidopa—Hypotension—Epirubicin—ovarian cancer	0.000147	0.00059	CcSEcCtD
Carbidopa—Dermatitis—Docetaxel—ovarian cancer	0.000147	0.00059	CcSEcCtD
Carbidopa—Confusional state—Doxorubicin—ovarian cancer	0.000147	0.000589	CcSEcCtD
Carbidopa—Headache—Docetaxel—ovarian cancer	0.000146	0.000587	CcSEcCtD
Carbidopa—Oedema—Doxorubicin—ovarian cancer	0.000146	0.000585	CcSEcCtD
Carbidopa—Infection—Doxorubicin—ovarian cancer	0.000145	0.000581	CcSEcCtD
Carbidopa—Shock—Doxorubicin—ovarian cancer	0.000143	0.000575	CcSEcCtD
Carbidopa—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000143	0.000572	CcSEcCtD
Carbidopa—Insomnia—Epirubicin—ovarian cancer	0.000142	0.000571	CcSEcCtD
Carbidopa—Paraesthesia—Epirubicin—ovarian cancer	0.000141	0.000567	CcSEcCtD
Carbidopa—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000141	0.000565	CcSEcCtD
Carbidopa—Dyspnoea—Epirubicin—ovarian cancer	0.00014	0.000563	CcSEcCtD
Carbidopa—Somnolence—Epirubicin—ovarian cancer	0.00014	0.000562	CcSEcCtD
Carbidopa—Anorexia—Doxorubicin—ovarian cancer	0.000139	0.000557	CcSEcCtD
Carbidopa—Nausea—Docetaxel—ovarian cancer	0.000139	0.000556	CcSEcCtD
Carbidopa—Dyspepsia—Epirubicin—ovarian cancer	0.000139	0.000556	CcSEcCtD
Carbidopa—Decreased appetite—Epirubicin—ovarian cancer	0.000137	0.000549	CcSEcCtD
Carbidopa—Hypotension—Doxorubicin—ovarian cancer	0.000136	0.000546	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000136	0.000545	CcSEcCtD
Carbidopa—Fatigue—Epirubicin—ovarian cancer	0.000136	0.000545	CcSEcCtD
Carbidopa—Pain—Epirubicin—ovarian cancer	0.000135	0.00054	CcSEcCtD
Carbidopa—Constipation—Epirubicin—ovarian cancer	0.000135	0.00054	CcSEcCtD
Carbidopa—Insomnia—Doxorubicin—ovarian cancer	0.000132	0.000529	CcSEcCtD
Carbidopa—Paraesthesia—Doxorubicin—ovarian cancer	0.000131	0.000525	CcSEcCtD
Carbidopa—Dyspnoea—Doxorubicin—ovarian cancer	0.00013	0.000521	CcSEcCtD
Carbidopa—Feeling abnormal—Epirubicin—ovarian cancer	0.00013	0.000521	CcSEcCtD
Carbidopa—DDC—SIDS Susceptibility Pathways—IL6—ovarian cancer	0.00013	0.0043	CbGpPWpGaD
Carbidopa—Somnolence—Doxorubicin—ovarian cancer	0.00013	0.00052	CcSEcCtD
Carbidopa—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000129	0.000517	CcSEcCtD
Carbidopa—Dyspepsia—Doxorubicin—ovarian cancer	0.000128	0.000515	CcSEcCtD
Carbidopa—Decreased appetite—Doxorubicin—ovarian cancer	0.000127	0.000508	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000126	0.000505	CcSEcCtD
Carbidopa—Fatigue—Doxorubicin—ovarian cancer	0.000126	0.000504	CcSEcCtD
Carbidopa—Urticaria—Epirubicin—ovarian cancer	0.000125	0.000502	CcSEcCtD
Carbidopa—Pain—Doxorubicin—ovarian cancer	0.000125	0.0005	CcSEcCtD
Carbidopa—Constipation—Doxorubicin—ovarian cancer	0.000125	0.0005	CcSEcCtD
Carbidopa—Body temperature increased—Epirubicin—ovarian cancer	0.000124	0.000499	CcSEcCtD
Carbidopa—Abdominal pain—Epirubicin—ovarian cancer	0.000124	0.000499	CcSEcCtD
Carbidopa—Feeling abnormal—Doxorubicin—ovarian cancer	0.00012	0.000482	CcSEcCtD
Carbidopa—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000119	0.000478	CcSEcCtD
Carbidopa—Hypersensitivity—Epirubicin—ovarian cancer	0.000116	0.000465	CcSEcCtD
Carbidopa—Urticaria—Doxorubicin—ovarian cancer	0.000116	0.000464	CcSEcCtD
Carbidopa—DDC—Circadian rythm related genes—TP53—ovarian cancer	0.000116	0.00383	CbGpPWpGaD
Carbidopa—Abdominal pain—Doxorubicin—ovarian cancer	0.000115	0.000462	CcSEcCtD
Carbidopa—Body temperature increased—Doxorubicin—ovarian cancer	0.000115	0.000462	CcSEcCtD
Carbidopa—Asthenia—Epirubicin—ovarian cancer	0.000113	0.000453	CcSEcCtD
Carbidopa—DDC—Metabolism—YAP1—ovarian cancer	0.000112	0.00373	CbGpPWpGaD
Carbidopa—Pruritus—Epirubicin—ovarian cancer	0.000111	0.000447	CcSEcCtD
Carbidopa—Diarrhoea—Epirubicin—ovarian cancer	0.000108	0.000432	CcSEcCtD
Carbidopa—Hypersensitivity—Doxorubicin—ovarian cancer	0.000107	0.000431	CcSEcCtD
Carbidopa—DDC—Circadian rythm related genes—IL6—ovarian cancer	0.000106	0.00351	CbGpPWpGaD
Carbidopa—Asthenia—Doxorubicin—ovarian cancer	0.000105	0.000419	CcSEcCtD
Carbidopa—Dizziness—Epirubicin—ovarian cancer	0.000104	0.000418	CcSEcCtD
Carbidopa—Pruritus—Doxorubicin—ovarian cancer	0.000103	0.000414	CcSEcCtD
Carbidopa—Vomiting—Epirubicin—ovarian cancer	0.0001	0.000402	CcSEcCtD
Carbidopa—Diarrhoea—Doxorubicin—ovarian cancer	9.97e-05	0.0004	CcSEcCtD
Carbidopa—Rash—Epirubicin—ovarian cancer	9.93e-05	0.000398	CcSEcCtD
Carbidopa—Dermatitis—Epirubicin—ovarian cancer	9.92e-05	0.000398	CcSEcCtD
Carbidopa—Headache—Epirubicin—ovarian cancer	9.87e-05	0.000396	CcSEcCtD
Carbidopa—Dizziness—Doxorubicin—ovarian cancer	9.64e-05	0.000387	CcSEcCtD
Carbidopa—Nausea—Epirubicin—ovarian cancer	9.35e-05	0.000375	CcSEcCtD
Carbidopa—Vomiting—Doxorubicin—ovarian cancer	9.26e-05	0.000372	CcSEcCtD
Carbidopa—Rash—Doxorubicin—ovarian cancer	9.19e-05	0.000369	CcSEcCtD
Carbidopa—Dermatitis—Doxorubicin—ovarian cancer	9.18e-05	0.000368	CcSEcCtD
Carbidopa—DDC—Metabolism—FASN—ovarian cancer	9.17e-05	0.00304	CbGpPWpGaD
Carbidopa—Headache—Doxorubicin—ovarian cancer	9.13e-05	0.000366	CcSEcCtD
Carbidopa—DDC—Metabolism—SLC5A5—ovarian cancer	9.02e-05	0.00299	CbGpPWpGaD
Carbidopa—DDC—Metabolism—SLC2A1—ovarian cancer	8.71e-05	0.00289	CbGpPWpGaD
Carbidopa—Nausea—Doxorubicin—ovarian cancer	8.66e-05	0.000347	CcSEcCtD
Carbidopa—DDC—Metabolism—CYP1B1—ovarian cancer	8.35e-05	0.00277	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PPP2R1A—ovarian cancer	7.41e-05	0.00246	CbGpPWpGaD
Carbidopa—DDC—Metabolism—ABCB1—ovarian cancer	6.88e-05	0.00228	CbGpPWpGaD
Carbidopa—DDC—Metabolism—TYMS—ovarian cancer	6.76e-05	0.00224	CbGpPWpGaD
Carbidopa—DDC—Metabolism—CAV1—ovarian cancer	5.44e-05	0.0018	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PIK3CG—ovarian cancer	4.96e-05	0.00164	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PIK3CD—ovarian cancer	4.36e-05	0.00144	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PIK3CB—ovarian cancer	3.8e-05	0.00126	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PTEN—ovarian cancer	3.28e-05	0.00109	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PIK3CA—ovarian cancer	2.32e-05	0.000768	CbGpPWpGaD
Carbidopa—DDC—Metabolism—AKT1—ovarian cancer	1.89e-05	0.000627	CbGpPWpGaD
